Dextromethorphan Hydrobromide/Chlorphenamine Maleate/Ammonium chloride

氢溴酸右美沙芬/马来酸氯苯那敏/氯化铵

Report date: 2025/07/22 15:56:36

Base Information

Drug NameDextromethorphan Hydrobromide/Chlorphenamine Maleate/Ammonium chloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsHistamine H1 receptor antagonists
TargetsGlutamate [NMDA] receptorHistamine H1 receptor
Therapy Area/IndicationsSneezingCoughNasal Obstruction
Global Approved IndicationsSneezingCoughNasal Obstruction
Approved Indications in ChinaSneezingCoughNasal Obstruction
Original Approved Country/TerritoryMainland China
Original Approved Date2015/01/14
Country/TerritoryMainland China
CombinationsYes Dextromethorphan HydrobromideChlorphenamine MaleateAmmonium Chloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAdvance Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSneezingCoughNasal Obstruction
Inactive IndicationsN/A

Other Information

ATC CodeR06AB54
Related LinksN/A